My first paper for 2024 is part of my PhD on understanding comorbid PTSD and bipolar disorder. Thank you to all of my international collaborators for your expertise on this work. It’s been a giant feat! @deakinresearch @IMPACTDeakin https://t.co/WERyYnSjFo
2 photos, same bathroom, almost 5 years apart. My first day and my last day at IMPACT, School of Medicine at Deakin University. I’ve had an amazing time learning, researching, collaborating, and making some fantastic friendships. I will miss all of you but won’t be far away.
It’s been an honour to work and collaborate with the researchers and clinicians at the University of Michigan Medicine throughout my PhD. Such a nice surprise to win an award for our work! @deakinmedia @DeakinHealth @deakinresearch @IMPACTDeakin 🤝👩🏼🎓💃 https://t.co/3NW4cfrTAK
I had the privilege to present my research work at @SMHR this week in Perth, and I won the rapid presentation award! So much fantastic mental health research happening and a great way to end the year #SMHR2023 @DeakinHealth #research#mentalhealth@IMPACTDeakin @deakinresearch
Proud to be an author of a new @theMJA supplement launched yesterday – the Future Healthy Countdown 2030. This national framework by @VicHealth, @MCRI_for_kids, & @ARACYAustralia will guide policy action, centring the health of our children. Learn more : https://t.co/jRVC1dZaL4
@ZJAyres Multiple different people have said something along the lines of “you looked at X and Y which is valid, but have you considered looking at X and Z?” no because I’m looking at X and Y.. I don’t understand the need to “devils advocate” existing research with unrelated feedback
Today I had the privilege of presenting two pieces of my PhD research work at the IMPACT Showcase at Deakin University. Such a fantastic day with brilliant presentations and people! #IMPACTDeakin#DeakinResearch#DeakinHealth
Major depressive disorder affects a large proportion of the population, with lifetime prevalence estimated to be 14.4%. Could N-acetylcysteine treatment assist in improving symptoms? Read our latest research here https://t.co/6hakJRCSA7 @IMPACTDeakin @deakinresearch #depression
Check out our new article, a systematic review looking to identify and explore the current medications for comorbid bipolar disorder and PTSD🧠#HaveAnIMPACT#DeakinResearch#MentalHealthMonth https://t.co/fNwNLsKJUm
It was a great experience to present my systematic review results (in person!) at the @IMPACTDeakin showcase this week. I forgot how much I missed socialising with everyone ❤️ #impactshowcase#haveanIMPACT#PhD#research
The impact of post-traumatic stress disorder in pharmacological intervention outcomes for adults with bipolar disorder: a protocol for a systematic review and meta-analysis. https://t.co/hCFA8s4JNO #medRxiv
Amazing work by @BPanizzutti et al exploring the molecular basis of anti-psychotic weight gain. Patterns related to lipid metabolism + biosynthesis are emerging, meaning we could look to treatments that increase myelination as a means to improve symptoms! #SMHR22
So excited to be a part of the Society for Mental Health Research conference #SMHR22 and the on demand symposium for my PhD research work on PTSD and bipolar disorder @SMHR
Brilliant virtual presentation by @droliviadean on the use of adjunct minocycline in the treatment of depression. So much promising data, and great to note the importance of data sharing to maximise power and analytic potential across clinical trials #SMHR22
What role does childhood trauma have in the treatment of bipolar disorder in adults? 🧠 A new paper from @droliviadean, @Marx_Wolf, @AlynaTurner, @EmmiSammy et al. Read here - https://t.co/hOf5ObYvmg